Recent Advancements in the Treatment of Rectal Gastrointestinal Stromal Tumor: In Era of Imatinib

Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumor of the gastrointestinal tract, with an annual incidence of 10–15 cases per million. However, rectal GIST has a low incidence, accounting for approximately 0.1% of all rectal tumors. The treatment of rectal GISTs is still co...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Hui, Xu, ZhaoHui, Ren, YanYing, Gong, ZeZhong, Ju, Ri Hyok, Zhang, Fan, Kang, HaoNan, Xu, Yang, Chen, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934706/
https://www.ncbi.nlm.nih.gov/pubmed/35321404
http://dx.doi.org/10.2147/CMAR.S352860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934706/
https://www.ncbi.nlm.nih.gov/pubmed/35321404
http://dx.doi.org/10.2147/CMAR.S352860

Ejemplares similares